Cargando…
Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity
Docetaxel is an effective drug for the treatment of metastatic breast cancer. However, the exact mechanisms and/or markers associated with chemosensitivity or resistance to docetaxel remain unclear. We previously showed that the expression of prostate apoptosis response 4 (PAR4) inhibits the growth...
Autores principales: | De Bessa Garcia, Simone Aparecida, Pavanelli, Ana Carolina, Melo, Natália Cruz E, Nagai, Maria Aparecida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360433/ https://www.ncbi.nlm.nih.gov/pubmed/28259909 http://dx.doi.org/10.3892/ijmm.2017.2900 |
Ejemplares similares
-
Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells
por: PEREIRA, MICHELLY C., et al.
Publicado: (2013) -
The Role of Prostate Apoptosis Response-4 (Par-4) in Mycobacterium tuberculosis Infected Macrophages
por: Han, Ji-Ye, et al.
Publicado: (2016) -
Role of PAR-4 in ovarian cancer
por: Meynier, Sonia, et al.
Publicado: (2015) -
Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis
por: Burikhanov, Ravshan, et al.
Publicado: (2014) -
Expression and Regulation of Prostate Apoptosis Response-4 (Par-4) in Human Glioma Stem Cells in Drug-Induced Apoptosis
por: Jagtap, Jayashree C., et al.
Publicado: (2014)